This NDC is on FDA's drug shortage list (posted Jul 14, 2023)
Reported reason: Shortage of an active ingredient
Product Information
LISDEXAMFETAMINE 50 MG CAPSULE is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $2.7042 per EA under NDC 00054037325. Its NADAC has been published 153 times since Sep 20, 2023.
FDA first approved this application on Aug 25, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054037325
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LISDEXAMFETAMINE DIMESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA202827FDA Approved
8/25/2023
TE Code
AB
On Market Since
8/25/2023
Pharmacological Classes
Price Statistics
The NADAC for LISDEXAMFETAMINE 50 MG CAPSULE has been published 153 times since Sep 20, 2023, and over the history we have for it it has declined 18.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7042 per EA |
|---|---|
| All-time high | $7.1516 (Mar 13, 2024) |
| All-time low | $2.4881 (Apr 17, 2024) |
| 52-week high | $3.7584 |
| 52-week low | $2.7042 |
| Median price | $3.7777 |
| Average price | $3.9935 |
| Largest weekly change | -48.8% (Apr 17, 2024) |
| Weeks tracked | 153 |
| Tracking since | Sep 20, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LISDEXAMFETAMINE 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 50 MG CAPSULE, manufactured by Hikma Pharmaceuticals USA Inc., is $2.7042 per EA (NDC 00054037325), effective Aug 19, 2026.
How has the price of LISDEXAMFETAMINE 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LISDEXAMFETAMINE 50 MG CAPSULE has declined 18.4%. It has been tracked across 153 weekly CMS publications since Sep 20, 2023.
What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 50 MG CAPSULE?
Since Sep 20, 2023, the NADAC for LISDEXAMFETAMINE 50 MG CAPSULE has ranged from a low of $2.4881 (Apr 17, 2024) to a high of $7.1516 (Mar 13, 2024), with a median of $3.7777 per EA.
Are there cheaper alternatives to LISDEXAMFETAMINE 50 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISDEXAMFETAMINE 50 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures LISDEXAMFETAMINE 50 MG CAPSULE?
LISDEXAMFETAMINE 50 MG CAPSULE (NDC 00054037325) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Is LISDEXAMFETAMINE 50 MG CAPSULE in shortage?
Yes — NDC 00054037325 is currently listed in FDA's drug shortage database (posted Jul 14, 2023). Reported reason: Shortage of an active ingredient.